Sunitigen-25
| Packed: |
25 mg / 28 Capsules |
|---|---|
| Manufacturer: |
Hetero Labs Limited |
| Active ingredient: |
Sunitinib |
Sunitigen (Sunitinib) is indicated for:
- Advanced and/or metastatic renal cell carcinoma (including cases where cytokine therapy has been ineffective).
- Gastrointestinal stromal tumors (GISTs) when imatinib therapy has failed to produce the desired effect.
- Unresectable or metastatic neuroendocrine tumors of the pancreas.
